Silo Pharma (SILO) Return on Sales (2019 - 2026)
Silo Pharma (SILO) posted Return on Sales of 0.91% for Q1 2026, down 86.85% sequentially from 0.49% in Q4 2025, and down 34.0% YoY from 1.38% in Q1 2025.
Silo Pharma (SILO) Return on Sales (2019 - 2026) Analysis & Trends
Silo Pharma has reported Return on Sales for 8 years, with the latest figure at 0.91% in Q1 2026.
- Quarterly Return on Sales fell 34.0% year-over-year to 0.91% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.67% (down 3.0% YoY) and the FY2025 annual result came in at 0.43%, up 11.0% from the prior year.
- Return on Sales eased to 0.91% in Q1 2026 per SILO's latest filing, from 0.49% in the prior quarter.
- Over five years, Return on Sales peaked at 0.02% in Q3 2022 and troughed at 1.01% in Q1 2023.
- A 5-year average of 0.51% and a median of 0.54% in 2023 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2023 and 2024: Return on Sales tumbled 58 bps in 2023, then soared 56 bps in 2024.
- Over 5 years, Return on Sales stood at 0.0% in 2022, then slumped by 612665 bps to 0.58% in 2023, then plunged by 65 bps to 0.96% in 2024, then jumped by 49 bps to 0.49% in 2025, then tumbled by 87 bps to 0.91% in 2026.
- According to Business Quant data, Return on Sales over the past three periods registered 0.91%, 0.49%, and 0.62% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Silo Pharma | 2.92 Mn | 2.92 Mn | - | -0.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.83% |
| Mar 31, 2026 | -0.91% |
| Dec 31, 2025 | -0.49% |
| Sep 30, 2025 | -0.62% |
| Jun 30, 2025 | -0.67% |
| Mar 31, 2025 | -0.57% |
| Dec 31, 2024 | -0.96% |
| Sep 30, 2024 | -0.52% |
| Jun 30, 2024 | -0.52% |
| Mar 31, 2024 | -0.44% |
| Dec 31, 2023 | -0.58% |
| Sep 30, 2023 | -0.37% |
| Jun 30, 2023 | -0.56% |
| Mar 31, 2023 | -1.01% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.02% |
| Jun 30, 2022 | 0.01% |
| Jun 30, 2021 | -0.01% |
| Mar 31, 2021 | -0.01% |
| Dec 31, 2020 | -0.09% |